BRICS Leaders Xiamen Declaration
Xiamen, China, 4 September 2017
64. We agree to enhance BRICS role in global health governance, especially in the context of the World Health Organization and UN agencies, and foster the development and improve the availability of innovative medical products through promotion of research and development and access to affordable, quality, effective and safe drugs, vaccines, diagnostics and other medical products and technologies as well as to medical services through enhanced health systems and health financing. We agree to improve surveillance capacity and medical services to combat infectious diseases, including Ebola, HIV/AIDS, Tuberculosis and Malaria, as well as non-communicable diseases and encourage greater application of ICTs to improve the level of health service provision. We welcome the outcomes of the BRICS Health Ministers Meeting and High-level Meeting on Traditional Medicine, and commend the establishment of a long-term mechanism for traditional medicine exchanges and cooperation, to promote mutual learning of traditional medicines and pass them down to future generations. We welcome the decision to set up the Tuberculosis Research Network, to be presented at the First WHO Global Ministerial Conference Ending Tuberculosis in the Sustainable Development Era: A Multisectoral Response, Moscow, Russian Federation, 16-17 November 2017. We express support for the meeting as well as the First United Nations General Assembly High-Level Meeting on Tuberculosis in 2018. We commit ourselves to enhanced cooperation at international fora on health matters including at G20.

To read more
Top News
Video
Press releases